Lyell Immunopharma (LYEL) Asset Utilization Ratio (2021 - 2025)
Historic Asset Utilization Ratio for Lyell Immunopharma (LYEL) over the last 5 years, with Q3 2025 value amounting to 0.0.
- Lyell Immunopharma's Asset Utilization Ratio rose 444.59% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year increase of 444.59%. This contributed to the annual value of 0.0 for FY2024, which is 3618.53% down from last year.
- According to the latest figures from Q3 2025, Lyell Immunopharma's Asset Utilization Ratio is 0.0, which was up 444.59% from 0.0 recorded in Q2 2025.
- In the past 5 years, Lyell Immunopharma's Asset Utilization Ratio ranged from a high of 0.09 in Q1 2023 and a low of 0.0 during Q2 2024
- Its 5-year average for Asset Utilization Ratio is 0.02, with a median of 0.01 in 2022.
- Per our database at Business Quant, Lyell Immunopharma's Asset Utilization Ratio soared by 106308.27% in 2023 and then crashed by 9989.83% in 2024.
- Lyell Immunopharma's Asset Utilization Ratio (Quarter) stood at 0.01 in 2021, then skyrocketed by 865.78% to 0.09 in 2022, then crashed by 99.81% to 0.0 in 2023, then tumbled by 34.69% to 0.0 in 2024, then fell by 5.96% to 0.0 in 2025.
- Its last three reported values are 0.0 in Q3 2025, 0.0 for Q2 2025, and 0.0 during Q1 2025.